Lung Cancer News

May 9, 2007

ALBUQUERQUE, N.M., May 8 — Biomoda, Inc. (BULLETIN BOARD: BMOD

Filed under: Uncategorized — admin @ 11:01 pm

ALBUQUERQUE, N.M., May 8 — Biomoda, Inc. (BULLETIN BOARD: BMOD
Earthtimes - “It is important that we use venues such as this to tell our outstanding story and to interest investors in Biomoda and our patented technologies for the early discovery of cancers including lung cancer,” said Mr. Cousins. “Safe Harbor” Statement

Epigenomics AG Enters into R&D Collaboration with Myriad Genetics Inc
Phramalive.com - product pipeline contains an extensively validated biomarker panel for the early detection of colorectal cancer in blood plasma, and further proprietary DNA methylation biomarkers at various stages of development for prostate and lung cancer

Free Press Bookstore
Detroit Free Press - Select a Health Topic ADD/ADHD Allergy Alternative Medicine Alzheimer’s Disease Arthritis Asthma Body Aches and Pains Breast Cancer Cancer Awareness Cardio Health Children’s Health Colon Cancer Contraception COPD/Emphysema Dental Health Diabetes Diet

Lung cancer chemo response predicted
United Press International - KNOXVILLE, Tenn., May 9 (UPI) — Patients with lung cancer who will respond to chemotherapy can be identified early in the course of their treatment, say U.S. researchers. “Although we studied a relatively small number of patients — and our results

Asbestos Disease Awareness Organization Releases New Findings on
Forbes - The occurrence of asbestos-related diseases, including mesothelioma, lung cancer and asbestosis, is growing out of control. Studies estimate that during the next decade, 100,000 victims in the United States will die of an asbestos related disease

Lawsuit: WA nursing home killed elderly woman with morphine
Seattle Times - TACOMA A new lawsuit accuses a Pierce County nursing home of killing a 79-year-old resident with excessive doses of morphine, while a lawyer for the home says the woman had inoperable lung cancer and had requested end-of-life “comfort care

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress